APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dydrogesterone Drug

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

Selected research

Market Analysis & Forecast

Global Dydrogesterone Drug Market Analysis and Forecast 2026-2032

Report ID 173987090228 December 2025198 pages

Choose your research edition.

Industry ResearchDydrogesterone Drug Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Dydrogesterone Drug Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Dydrogesterone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dydrogesterone Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dydrogesterone Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

The classification of Dydrogesterone Drug includes Dydrogesterone and Dydrogesterone +Estradiol Compound, and the sale proportion of Dydrogesterone in 2019 is about 75.22%.

Dydrogesterone Drug is widely used for Infertility, Gynecological Diseases, Threatened Abortion, etc. The most proportion of Dydrogesterone Drug is used for Infertility, and the proportion in 2019 is 67.71%.

Read the full market overview

There are mainly two manufacturers in this industry, which is Abbott and Viatris，and their production are in Europe and USA respectively.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 62.27% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 15.77%.

This report presents an overview of global market for Dydrogesterone Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dydrogesterone Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Dydrogesterone Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dydrogesterone Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dydrogesterone Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dydrogesterone Drug sales, projected growth trends, production technology, application and end-user industry.

Dydrogesterone Drug Segment by Company

Abbott

Viatris

Dydrogesterone Drug Segment by Type

Dydrogesterone

Dydrogesterone+Estradiol Compound

Dydrogesterone Drug Segment by Application

Infertility

Gynecological Diseases

Threatened Abortion

Other

Dydrogesterone Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dydrogesterone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dydrogesterone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dydrogesterone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dydrogesterone Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dydrogesterone Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dydrogesterone Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dydrogesterone Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dydrogesterone Major Manufacturers Table 3. Dydrogesterone+Estradiol Compound Major Manufacturers Table 4. Global Dydrogesterone Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Infertility Major Manufacturers Table 6. Gynecological Diseases Major Manufacturers Table 7. Threatened Abortion Major Manufacturers Table 8. Other Major Manufacturers Table 9. Dydrogesterone Drug Industry Trends Table 10. Dydrogesterone Drug Industry Drivers Table 11. Dydrogesterone Drug Industry Opportunities and Challenges Table 12. Dydrogesterone Drug Industry Restraints Table 13. Global Dydrogesterone Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Dydrogesterone Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Dydrogesterone Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Dydrogesterone Drug Revenue Market Share by Region (2021-2026) Table 17. Global Dydrogesterone Drug Revenue Market Share by Region (2027-2032) Table 18. Global Dydrogesterone Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 19. Global Dydrogesterone Drug Sales by Region (2021-2026) & (Units) Table 20. Global Dydrogesterone Drug Sales by Region (2027-2032) & (Units) Table 21. Global Dydrogesterone Drug Sales Market Share by Region (2021-2026) Table 22. Global Dydrogesterone Drug Sales Market Share by Region (2027-2032) Table 23. Global Dydrogesterone Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Dydrogesterone Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Dydrogesterone Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Dydrogesterone Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Dydrogesterone Drug Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 28. Global Dydrogesterone Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Dydrogesterone Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Dydrogesterone Drug Manufacturers, Product Type & Application Table 31. Global Dydrogesterone Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Dydrogesterone Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Dydrogesterone Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Dydrogesterone Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Dydrogesterone Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Dydrogesterone Drug Revenue Market Share by Type (2021-2026) Table 38. Global Dydrogesterone Drug Revenue Market Share by Type (2027-2032) Table 39. Global Dydrogesterone Drug Sales by Type 2021 VS 2025 VS 2032 (Units) Table 40. Global Dydrogesterone Drug Sales by Type (2021-2026) & (Units) Table 41. Global Dydrogesterone Drug Sales by Type (2027-2032) & (Units) Table 42. Global Dydrogesterone Drug Sales Market Share by Type (2021-2026) Table 43. Global Dydrogesterone Drug Sales Market Share by Type (2027-2032) Table 44. Global Dydrogesterone Drug Price by Type (2021-2026) & (USD/Unit) Table 45. Global Dydrogesterone Drug Price by Type (2027-2032) & (USD/Unit) Table 46. Global Dydrogesterone Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Dydrogesterone Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Dydrogesterone Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Dydrogesterone Drug Revenue Market Share by Application (2021-2026) Table 50. Global Dydrogesterone Drug Revenue Market Share by Application (2027-2032) Table 51. Global Dydrogesterone Drug Sales by Application 2021 VS 2025 VS 2032 (Units) Table 52. Global Dydrogesterone Drug Sales by Application (2021-2026) & (Units) Table 53. Global Dydrogesterone Drug Sales by Application (2027-2032) & (Units) Table 54. Global Dydrogesterone Drug Sales Market Share by Application (2021-2026) Table 55. Global Dydrogesterone Drug Sales Market Share by Application (2027-2032) Table 56. Global Dydrogesterone Drug Price by Application (2021-2026) & (USD/Unit) Table 57. Global Dydrogesterone Drug Price by Application (2027-2032) & (USD/Unit) Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Dydrogesterone Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Abbott Dydrogesterone Drug Product Portfolio Table 62. Abbott Recent Development Table 63. Viatris Company Information Table 64. Viatris Business Overview Table 65. Viatris Dydrogesterone Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Viatris Dydrogesterone Drug Product Portfolio Table 67. Viatris Recent Development Table 68. North America Dydrogesterone Drug Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Dydrogesterone Drug Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Dydrogesterone Drug Sales by Type (2021-2026) & (Units) Table 71. North America Dydrogesterone Drug Sales by Type (2027-2032) & (Units) Table 72. North America Dydrogesterone Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 73. North America Dydrogesterone Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 74. North America Dydrogesterone Drug Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Dydrogesterone Drug Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Dydrogesterone Drug Sales by Application (2021-2026) & (Units) Table 77. North America Dydrogesterone Drug Sales by Application (2027-2032) & (Units) Table 78. North America Dydrogesterone Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 79. North America Dydrogesterone Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 80. North America Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Dydrogesterone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Dydrogesterone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 84. North America Dydrogesterone Drug Sales by Country (2021-2026) & (Units) Table 85. North America Dydrogesterone Drug Sales by Country (2027-2032) & (Units) Table 86. North America Dydrogesterone Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 87. North America Dydrogesterone Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 88. United States Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 89. Canada Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 90. Mexico Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 91. Europe Dydrogesterone Drug Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Dydrogesterone Drug Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Dydrogesterone Drug Sales by Type (2021-2026) & (Units) Table 94. Europe Dydrogesterone Drug Sales by Type (2027-2032) & (Units) Table 95. Europe Dydrogesterone Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 96. Europe Dydrogesterone Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 97. Europe Dydrogesterone Drug Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Dydrogesterone Drug Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Dydrogesterone Drug Sales by Application (2021-2026) & (Units) Table 100. Europe Dydrogesterone Drug Sales by Application (2027-2032) & (Units) Table 101. Europe Dydrogesterone Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 102. Europe Dydrogesterone Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 103. Europe Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Dydrogesterone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Dydrogesterone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 107. Europe Dydrogesterone Drug Sales by Country (2021-2026) & (Units) Table 108. Europe Dydrogesterone Drug Sales by Country (2027-2032) & (Units) Table 109. Europe Dydrogesterone Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 110. Europe Dydrogesterone Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 111. Germany Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 112. France Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 113. U.K. Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 114. Italy Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 115. Russia Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 116. Spain Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 119. Sweden Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 120. Poland Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 121. China Dydrogesterone Drug Revenue by Type (2021-2026) & (US$ Million) Table 122. China Dydrogesterone Drug Revenue by Type (2027-2032) & (US$ Million) Table 123. China Dydrogesterone Drug Sales by Type (2021-2026) & (Units) Table 124. China Dydrogesterone Drug Sales by Type (2027-2032) & (Units) Table 125. China Dydrogesterone Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 126. China Dydrogesterone Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 127. China Dydrogesterone Drug Revenue by Application (2021-2026) & (US$ Million) Table 128. China Dydrogesterone Drug Revenue by Application (2027-2032) & (US$ Million) Table 129. China Dydrogesterone Drug Sales by Application (2021-2026) & (Units) Table 130. China Dydrogesterone Drug Sales by Application (2027-2032) & (Units) Table 131. China Dydrogesterone Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 132. China Dydrogesterone Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 133. Asia Dydrogesterone Drug Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Dydrogesterone Drug Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Dydrogesterone Drug Sales by Type (2021-2026) & (Units) Table 136. Asia Dydrogesterone Drug Sales by Type (2027-2032) & (Units) Table 137. Asia Dydrogesterone Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 138. Asia Dydrogesterone Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 139. Asia Dydrogesterone Drug Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Dydrogesterone Drug Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Dydrogesterone Drug Sales by Application (2021-2026) & (Units) Table 142. Asia Dydrogesterone Drug Sales by Application (2027-2032) & (Units) Table 143. Asia Dydrogesterone Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 144. Asia Dydrogesterone Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 145. Asia Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Dydrogesterone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Dydrogesterone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 149. Asia Dydrogesterone Drug Sales by Country (2021-2026) & (Units) Table 150. Asia Dydrogesterone Drug Sales by Country (2027-2032) & (Units) Table 151. Asia Dydrogesterone Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 152. Asia Dydrogesterone Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 153. Japan Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 154. South Korea Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 155. India Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 156. Australia Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Dydrogesterone Drug Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Dydrogesterone Drug Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Dydrogesterone Drug Sales by Type (2021-2026) & (Units) Table 162. SAMEA Dydrogesterone Drug Sales by Type (2027-2032) & (Units) Table 163. SAMEA Dydrogesterone Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 164. SAMEA Dydrogesterone Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 165. SAMEA Dydrogesterone Drug Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Dydrogesterone Drug Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Dydrogesterone Drug Sales by Application (2021-2026) & (Units) Table 168. SAMEA Dydrogesterone Drug Sales by Application (2027-2032) & (Units) Table 169. SAMEA Dydrogesterone Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 170. SAMEA Dydrogesterone Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 171. SAMEA Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Dydrogesterone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Dydrogesterone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 175. SAMEA Dydrogesterone Drug Sales by Country (2021-2026) & (Units) Table 176. SAMEA Dydrogesterone Drug Sales by Country (2027-2032) & (Units) Table 177. SAMEA Dydrogesterone Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 178. SAMEA Dydrogesterone Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 179. Brazil Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 180. Argentina Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 181. Chile Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 182. Colombia Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 183. Peru Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 185. Israel Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 186. UAE Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 187. Turkey Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 188. Iran Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 189. Egypt Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Dydrogesterone Drug Distributors List Table 193. Dydrogesterone Drug Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Dydrogesterone Drug Image Figure 2. Global Dydrogesterone Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dydrogesterone Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dydrogesterone Image Figure 5. Dydrogesterone+Estradiol Compound Image Figure 6. Global Dydrogesterone Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dydrogesterone Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Infertility Image Figure 9. Gynecological Diseases Image Figure 10. Threatened Abortion Image Figure 11. Other Image Figure 12. Global Dydrogesterone Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Dydrogesterone Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Dydrogesterone Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Dydrogesterone Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Dydrogesterone Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Dydrogesterone Drug Sales (2021-2032) & (Units) Figure 18. Global Dydrogesterone Drug Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 19. Global Dydrogesterone Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Dydrogesterone Drug Sales YoY (2021-2032) & (Units) Figure 21. Europe Dydrogesterone Drug Sales YoY (2021-2032) & (Units) Figure 22. China Dydrogesterone Drug Sales YoY (2021-2032) & (Units) Figure 23. Asia (Excluding China) Dydrogesterone Drug Sales YoY (2021-2032) & (Units) Figure 24. South America, Middle East and Africa Dydrogesterone Drug Sales YoY (2021-2032) & (Units) Figure 25. Global Dydrogesterone Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Dydrogesterone Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Dydrogesterone Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Dydrogesterone Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Dydrogesterone Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Dydrogesterone Drug Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 32. Global Dydrogesterone Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Dydrogesterone Drug Sales Market Share by Type (2021-2032) Figure 34. Global Dydrogesterone Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Dydrogesterone Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Dydrogesterone Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Dydrogesterone Drug Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 38. Global Dydrogesterone Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Dydrogesterone Drug Sales Market Share by Application (2021-2032) Figure 40. North America Dydrogesterone Drug Revenue Share by Type (2021-2032) Figure 41. North America Dydrogesterone Drug Sales Share by Type (2021-2032) Figure 42. North America Dydrogesterone Drug Revenue Share by Application (2021-2032) Figure 43. North America Dydrogesterone Drug Sales Share by Application (2021-2032) Figure 44. North America Dydrogesterone Drug Revenue Share by Country (2021-2032) Figure 45. North America Dydrogesterone Drug Sales Share by Country (2021-2032) Figure 46. Europe Dydrogesterone Drug Revenue Share by Type (2021-2032) Figure 47. Europe Dydrogesterone Drug Sales Share by Type (2021-2032) Figure 48. Europe Dydrogesterone Drug Revenue Share by Application (2021-2032) Figure 49. Europe Dydrogesterone Drug Sales Share by Application (2021-2032) Figure 50. Europe Dydrogesterone Drug Revenue Share by Country (2021-2032) Figure 51. Europe Dydrogesterone Drug Sales Share by Country (2021-2032) Figure 52. China Dydrogesterone Drug Revenue Share by Type (2021-2032) Figure 53. China Dydrogesterone Drug Sales Share by Type (2021-2032) Figure 54. China Dydrogesterone Drug Revenue Share by Application (2021-2032) Figure 55. China Dydrogesterone Drug Sales Share by Application (2021-2032) Figure 56. Asia Dydrogesterone Drug Revenue Share by Type (2021-2032) Figure 57. Asia Dydrogesterone Drug Sales Share by Type (2021-2032) Figure 58. Asia Dydrogesterone Drug Revenue Share by Application (2021-2032) Figure 59. Asia Dydrogesterone Drug Sales Share by Application (2021-2032) Figure 60. Asia Dydrogesterone Drug Revenue Share by Country (2021-2032) Figure 61. Asia Dydrogesterone Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Dydrogesterone Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Dydrogesterone Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Dydrogesterone Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Dydrogesterone Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Dydrogesterone Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Dydrogesterone Drug Sales Share by Country (2021-2032) Figure 68. Dydrogesterone Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Dydrogesterone Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dydrogesterone
  • Dydrogesterone+Estradiol Compound
Applications
  • Infertility
  • Gynecological Diseases
  • Threatened Abortion
  • Other
Companies covered
  • Abbott
  • Viatris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dydrogesterone Drug Market by Type
  3. 1.2.1 Global Dydrogesterone Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dydrogesterone
  5. 1.2.3 Dydrogesterone+Estradiol Compound
  6. 1.3 Dydrogesterone Drug Market by Application
  7. 1.3.1 Global Dydrogesterone Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Infertility
  9. 1.3.3 Gynecological Diseases
  10. 1.3.4 Threatened Abortion
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Dydrogesterone Drug Market Dynamics
  1. 2.1 Dydrogesterone Drug Industry Trends
  2. 2.2 Dydrogesterone Drug Industry Drivers
  3. 2.3 Dydrogesterone Drug Industry Opportunities and Challenges
  4. 2.4 Dydrogesterone Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dydrogesterone Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dydrogesterone Drug Revenue by Region
  3. 3.2.1 Global Dydrogesterone Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dydrogesterone Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Dydrogesterone Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Dydrogesterone Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dydrogesterone Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dydrogesterone Drug Sales by Region
  9. 3.4.1 Global Dydrogesterone Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dydrogesterone Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Dydrogesterone Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Dydrogesterone Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dydrogesterone Drug Revenue by Manufacturers
  2. 4.1.1 Global Dydrogesterone Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dydrogesterone Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dydrogesterone Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dydrogesterone Drug Sales by Manufacturers
  6. 4.2.1 Global Dydrogesterone Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dydrogesterone Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dydrogesterone Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dydrogesterone Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dydrogesterone Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dydrogesterone Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dydrogesterone Drug Manufacturers, Product Type & Application
  13. 4.7 Global Dydrogesterone Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dydrogesterone Drug Market CR5 and HHI
  16. 4.8.2 2025 Dydrogesterone Drug Tier 1, Tier 2, and Tier 3
5 Dydrogesterone Drug Market by Type
  1. 5.1 Global Dydrogesterone Drug Revenue by Type
  2. 5.1.1 Global Dydrogesterone Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dydrogesterone Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dydrogesterone Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dydrogesterone Drug Sales by Type
  6. 5.2.1 Global Dydrogesterone Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dydrogesterone Drug Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Dydrogesterone Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dydrogesterone Drug Price by Type
6 Dydrogesterone Drug Market by Application
  1. 6.1 Global Dydrogesterone Drug Revenue by Application
  2. 6.1.1 Global Dydrogesterone Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dydrogesterone Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dydrogesterone Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dydrogesterone Drug Sales by Application
  6. 6.2.1 Global Dydrogesterone Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dydrogesterone Drug Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Dydrogesterone Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dydrogesterone Drug Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Dydrogesterone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Dydrogesterone Drug Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Viatris
  8. 7.2.1 Viatris Company Information
  9. 7.2.2 Viatris Business Overview
  10. 7.2.3 Viatris Dydrogesterone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Viatris Dydrogesterone Drug Product Portfolio
  12. 7.2.5 Viatris Recent Developments
8 North America
  1. 8.1 North America Dydrogesterone Drug Market Size by Type
  2. 8.1.1 North America Dydrogesterone Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Dydrogesterone Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Dydrogesterone Drug Price by Type (2021-2032)
  5. 8.2 North America Dydrogesterone Drug Market Size by Application
  6. 8.2.1 North America Dydrogesterone Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Dydrogesterone Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Dydrogesterone Drug Price by Application (2021-2032)
  9. 8.3 North America Dydrogesterone Drug Market Size by Country
  10. 8.3.1 North America Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dydrogesterone Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dydrogesterone Drug Market Size by Type
  2. 9.1.1 Europe Dydrogesterone Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dydrogesterone Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Dydrogesterone Drug Price by Type (2021-2032)
  5. 9.2 Europe Dydrogesterone Drug Market Size by Application
  6. 9.2.1 Europe Dydrogesterone Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dydrogesterone Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Dydrogesterone Drug Price by Application (2021-2032)
  9. 9.3 Europe Dydrogesterone Drug Market Size by Country
  10. 9.3.1 Europe Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dydrogesterone Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dydrogesterone Drug Market Size by Type
  2. 10.1.1 China Dydrogesterone Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Dydrogesterone Drug Sales by Type (2021-2032)
  4. 10.1.3 China Dydrogesterone Drug Price by Type (2021-2032)
  5. 10.2 China Dydrogesterone Drug Market Size by Application
  6. 10.2.1 China Dydrogesterone Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Dydrogesterone Drug Sales by Application (2021-2032)
  8. 10.2.3 China Dydrogesterone Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dydrogesterone Drug Market Size by Type
  2. 11.1.1 Asia Dydrogesterone Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dydrogesterone Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Dydrogesterone Drug Price by Type (2021-2032)
  5. 11.2 Asia Dydrogesterone Drug Market Size by Application
  6. 11.2.1 Asia Dydrogesterone Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dydrogesterone Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Dydrogesterone Drug Price by Application (2021-2032)
  9. 11.3 Asia Dydrogesterone Drug Market Size by Country
  10. 11.3.1 Asia Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dydrogesterone Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dydrogesterone Drug Market Size by Type
  2. 12.1.1 SAMEA Dydrogesterone Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dydrogesterone Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dydrogesterone Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Dydrogesterone Drug Market Size by Application
  6. 12.2.1 SAMEA Dydrogesterone Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dydrogesterone Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dydrogesterone Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Dydrogesterone Drug Market Size by Country
  10. 12.3.1 SAMEA Dydrogesterone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dydrogesterone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dydrogesterone Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dydrogesterone Drug Value Chain Analysis
  2. 13.1.1 Dydrogesterone Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dydrogesterone Drug Production Mode & Process
  6. 13.2 Dydrogesterone Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dydrogesterone Drug Distributors
  9. 13.2.3 Dydrogesterone Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst